Navigation Links
Antibody library project could unlock mysteries of human gene function
Date:11/1/2011

LOS ALAMOS, New Mexico, October 31, 2011 A National Institutes of Health (NIH) grant to Los Alamos National Laboratory Bioscience Division could help unravel the gnarly secrets of how many human genes function.

Originally discovered in the Human Genome Project, the approximately 20,000 genes of the human body have been slow to reveal their exact roles. And one of the best tools for exposing a gene's function is to take the protein it produces and generate specific antibodies, usually by vaccinating mice or rabbits. Antibodies are specialized proteins the immune system deploys to block the actions of potentially harmful bacteria and viruses.

By looking at antibodies, researchers can identify where, in a cell, genes are active and under what conditions they increase or decrease their expression. Antibodies are also one of the fastest growing classes of new therapeutics,with sales of about $40 billion in 2010.

With the new NIH Common Fund grant of more than $4 million, researchers led by Andrew Bradbury aim to develop an automated pipeline to generate antibodies against human gene products, without using animals.

Instead Dr. Bradbury's team will use "antibody libraries" expressed in bacteria and bakers yeast. These libraries are enormous, comprising billions of different antibodies, and the ultimate goal is to identify antibodies in the libraries that recognize each human protein. The broad availability of antibodies against all human proteins will facilitate the understanding of human disease and provide likely targets for therapeutic intervention, with the antibodies themselves potentially becoming therapeutic leads.

This project will leverage much of the technology that has been developed over the years at LANL, including flow cytometry, antibody libraries and fluorescentprotein technology, and has the potential to create a set of tools applicable to many different problems of interest to sponsors beyond NIH, including the U.S. Department of Energy and Department of Defense.


'/>"/>

Contact: Nancy Ambrosiano
nwa@lanl.gov
505-667-0471
DOE/Los Alamos National Laboratory
Source:Eurekalert

Related biology news :

1. Xencor Initiates Phase 1 Study of XmAb®5871 Therapeutic Antibody for the Treatment of Autoimmune Diseases
2. B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome
3. Scientists report major advance in human antibody therapy against deadly Hendra virus
4. Powerful antibody-based strategy suggests a new therapeutic approach to diabetes and obesity
5. Humabs discovers the first antibody to neutralize both group 1 and group 2 influenza A viruses
6. Discovery of natural antibody brings a universal flu vaccine a step closer
7. Epitomics Signs Agreement With Bayer for Antibody Technology
8. Researchers discover trigger to early, effective antibody response
9. Plastic antibody works in first tests in living animals
10. USU scientists report major advance in human antibody therapy against deadly Nipah virus
11. First human gets new antibody aimed at rabies virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- RSA, ... that is designed to enhance fraud detection and ... in the RSA Fraud & Risk Intelligence Suite. ... to leverage additional insights from internal and external ... better protect their customers from targeted cybercrime attacks. ...
(Date:2/9/2017)... LONDON , Feb. 9, 2017 The ... in-depth analysis of the biomass boiler market globally in ... sales of biomass boilers. The market for biomass boilers ... product type, end-user, application, and country/region. The market based ... agriculture & forest residues, biogas & energy crops, urban ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)... MENLO PARK, Calif., March 23, 2017  BioPharmX ... developing products for the dermatology market, today reported ... Jan. 31, 2017, and will provide an update ... from the year. "We are pleased ... productive year for BioPharmX," said President Anja Krammer. ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/23/2017)... -- In today,s pre-market research, Stock-Callers.com takes ... industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals Inc. ... Regulus Therapeutics Inc. (NASDAQ: RGLS ). On ... rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more about ... ...
Breaking Biology Technology: